Berkshire Hathaway and Appaloosa Management significantly reduced or fully exited their UnitedHealth Group positions in Q1 2026 despite strong recent earnings and raised guidance. The exits reflect concerns over shrinking Medicare Advantage membership, lower-than-expected 2027 rate announcements, high denial rates for post-hospital care, and slower profitability recovery at Optum Health. While sell-side analysts remain bullish with a $407 target, these institutional moves highlight risks that could pressure UnitedHealth's medical care ratio and future margins. Investors should consider these factors carefully before assuming the recent stock rally signals a full recovery.
Berkshire Hathaway, led by CEO Greg Abel, acquired nearly 40 million shares of Delta Air Lines worth about $2.65 billion, marking a significant shift from Warren Buffett's 2020 airline exit. Delta's strong financials, including record free cash flow ...
The Health Care Select Sector SPDR ETF (XLV) is down about 3% year-to-date despite a 14% gain over the past year. The fund's performance hinges on drug pricing policies and key product pricing, especially from Eli Lilly, which dominates XLV with its ...
The global healthcare services market, valued at $8.62 trillion in 2025, is projected to grow to $20.10 trillion by 2035 at a CAGR of 8.87%. Growth is driven by rising chronic diseases, aging populations, and increased demand for personalized and acc...
